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Abstract: During the vesicular trafficking process, cellular membranes undergo dynamic 
morphological changes, in particular at the vesicle generation and fusion steps. Changes in 
membrane shape are regulated by small GTPases, coat proteins and other accessory 
proteins, such as BAR domain-containing proteins. In addition, membrane deformation 
entails changes in the lipid composition as well as asymmetric distribution of lipids over 
the two leaflets of the membrane bilayer. Given that P4-ATPases, which catalyze 
unidirectional flipping of lipid molecules from the exoplasmic to the cytoplasmic leaflets 
of the bilayer, are crucial for the trafficking of proteins in the secretory and endocytic 
pathways, changes in the lipid composition are involved in the vesicular trafficking process. 
Membrane remodeling is under complex regulation that involves the composition and 
distribution of lipids as well as assembly of proteins.   
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1. Introduction 
Biological membranes not only separate the interior of the cell from the external environment, but 
also bring about compartmentalization of distinct subcellular organelles. Intracellular compartments 
along the secretory and endocytic pathways communicate with one another through membrane 
trafficking, specifically that mediated by carrier vesicles. Membrane trafficking ensures delivery of 
appropriate materials, such as proteins and lipids, in order to maintain the identity of these organelles. 
Dynamic membrane shape changes occur during formation of the vesicles and tubules that mediate 
cargo delivery in the secretory and endocytic pathways. These carrier intermediates vary in shape, 
from small vesicles (~50 nm) and thin tubules to tubular-saccular carriers [1–3].  
Upon membrane deformation, a selected membrane subdomain is curved, sensed and stabilized by a 
variety of proteins. Formation of carrier intermediates is driven through a complex process that 
involves modification and changes in composition and distribution of lipids, as well as local assembly 
of coat protein complexes and proteins involved in sensing and forming membrane curvature. In 
particular, insertion of amphipathic helices into the membrane subdomain is required for curvature 
generation; proteins containing BAR (Bin/Amphiphysin/Rvs) domains, which form a crescent-like 
homodimer, are required for sensing and stabilizing this curvature. Here, we will introduce the idea of 
local curvature generation via changes in the inter-leaflet distribution of lipids, catalyzed by 
P4-ATPases, and insertion of the amphipathic helices of Arf family small GTPases. Furthermore,  
we will discuss how the curvature is stabilized by BAR domain proteins. We also consider the 
interplays among these proteins that generate and stabilize membrane curvature in the context of 
membrane trafficking.   
2. Lipids 
2.1. Relationship between Asymmetric Lipid Distribution and Membrane Deformation 
Lipid bilayers, including those of the plasma membrane and the membrane-enclosed compartments 
along the secretory and endocytic pathways, exhibit asymmetric lipid distributions. In particular, 
aminophospholipids, phosphatidylserine (PS) and phosphatidylethanolamine (PE) are enriched in the 
cytoplasmic leaflet. For example, in resting human red blood cells, PS and PE are restricted primarily 
to the inner/cytoplasmic leaflet of the plasma membrane, whereas phosphatidylcholine (PC) and 
sphingomyelin (SM) are exposed on the cell surface [4,5]. Regulated exposure of PS in the 
outer/exoplasmic leaflet occurs during a variety of biological processes, such as apoptotic cell death, 
platelet coagulation and myotube formation [5–8]. On the other hand, PE is exposed on the surface of 
the cleavage furrow during cytokinesis [9].  
Drastic cell shape changes occur upon exogenous application of lyso-PC or impermeable 
amphipathic drugs. The former flips into the inner leaflet of the bilayer at a slow rate; the latter 
intercalate only into the exterior leaflet of the bilayer; these phenomena can be explained by the bilayer 
couple mechanism [10,11]. Moreover, insertion of lyso-PC into a giant unilamellar vesicle induces 
formation of a single bud [12]. These observations suggest that changes in distribution of specific Membranes 2012, 2     120 
 
lipids between the two leaflets of bilayers are able to drive membrane deformation.   
2.2. Phospholipid Flippases (P4-ATPases) 
An ATP-dependent “flippase” (also called aminophospholipid translocase) activity in the plasma 
membrane of human erythrocytes was discovered by Seigneuret and Devaux [13]. Subsequently, 
P4-ATPases, a subfamily of P-type ATPases, were recognized as the most likely candidates for 
flippases in eukaryotic membranes [14–16]. P4-ATPases have been implicated in flipping 
aminophospholipids from the exoplasmic/lumenal leaflet to the cytoplasmic leaflet of cellular 
membranes [14,17–20]. In yeast, it has also been reported that even PC can be translocated by 
P4-ATPases [18]. 
Molecular biological approaches in yeasts and worm have revealed that the absence of specific 
P4-ATPases results in defects in membrane trafficking [14,15,18,21–24]. In the yeast Saccharomyces 
cerevisiae, five P4-ATPases are encoded in the genome (Table 1), and are involved in trafficking of 
proteins at different stages along the secretory and endocytic pathways [25]. For example, a drs2-ts 
mutant at the non-permissive temperature inhibits translocation of fluorescently labeled PS [26] and 
formation of post-Golgi vesicles [27], indicating that Drs2p is required to flip PS to the cytoplasmic 
leaflet of membranes in order to support vesicle formation from the trans-Golgi network (TGN). 
Alder-Baerens  et al. [28] showed that loss of Drs2p and Dnf3p disrupts aminophospholipid 
translocation and phospholipid asymmetry in yeast post-Golgi secretory vesicles. In other organisms, 
including Caenorhabditis elegans and Arabidopsis thaliana, P4-ATPases also play essential roles in 
membrane trafficking [22,23,29]. For example, Poulsen et al. [29] showed that mutations of ALA3  
(a P4-ATPase in A. thaliana) result in impaired production of secretory vesicles from the Golgi. These 
findings confirm the critical roles of lipid flippases in vesicle formation. P4-ATPases may induce 
membrane bending via changing the distribution of phospholipids between the two leaflets of bilayers 
(Figure 1A). 
Table 1. P4-ATpases in human, yeast, worm and plant. 
Class  Human  S. cerevisiae  C. elegans  A. thaliana
1a ATP8A1,  ATP8A2  DRS2  TAT-1  ALA1 
1b 
ATP8B1, ATP8B2, 
ATP8B3, ATP8B4 
- TAT-2 
ALA2-12 
2 ATP9A,  ATP9B  NEO1  TAT-5,  TAT-6 
3 -  DNF1,  DNF2 - 
4 -  DNF3  - 
5  ATP10A, ATP10B, ATP10D -  TAT-3, TAT-4 
6  ATP11A, ATP11B, ATP11C  -  - 
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Figure 1. Mechanistic model for the generation of membrane curvature. (A) Membrane 
deforming mechanism (i) Lipid composition is changed by P4-ATPases, LPAT and PLA2; 
(ii) amphipathic helices of Arf family small GTPases are inserted into the cytoplasmic 
leaflet of the membrane; and (iii) the resultant curvature is sensed and stabilized by BAR 
domain proteins; (B) Helical-wheel representation of the N-terminal amphipathic helix of 
Arf1 (amino acids 2-13); (C) Structure of the BAR domain dimer of arfaptin. Image from 
the RCSB PDB [30] of PDB ID 1I49 [31]; (D)  The complex regulation of proteins 
involved in generating membrane curvature.   
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Although there has been no direct evidence indicating that mammalian P4-ATPases also play 
essential roles in membrane trafficking, earlier studies showed that changes in lipid composition are 
involved in vesicular trafficking in a human erythroleukemia cell line, K562 [32]: endocytosis is 
stimulated by extracellular application of PS or PE, but partially inhibited by the addition of lyso-PS, 
which cannot translocate across the plasma membrane [32]. Thus, it is likely that the plasma 
membrane phospholipid asymmetry produces a driving force for budding of endocytic vesicles in 
mammalian cells as well. 
Mammalian P4-ATPases have been implicated in various pathophysiologic processes. Among the 
14 P4-ATPases (Table 1), mutations of ATP8B1 (FIC1) have been reported to cause familial 
intrahepatic cholestasis [33]. Furthermore, in ATP8B1-deficient mice, a significant amount of PS was 
observed in bile after infusion of bile salts, suggesting that ATP8B1 deficiency causes exposure of PS 
in the outer leaflet of the apical plasma membrane of bile canalicular cells [34]. The ATP8B3 gene is 
expressed in spermatocytes and spermatids [35]. In ATP8B3-null sperm cells, PS exposure was 
detectable before capacitation; the aberrantly early exposure of PS may affect the capacitation  
process [35]. The mouse ATP10A gene (also called ATP10C) is linked to diet-induced obesity and type 
II diabetes phenotypes [36], and an ATP10D mutation shows linkage to a fat-prone phenotype in 
certain strains of mice [37,38]. Recently, ATP11C has been shown to participate in the B lymphocyte 
differentiation [39,40]. Together, these observations imply that the asymmetric distribution of 
phospholipids in biological membranes maintained/regulated by P4-ATPases plays crucial roles in 
mammalian pathophysiology. However, the involvement of mammalian P4-ATPases in membrane 
trafficking, and the functional relationship between the P4-ATPase−related pathophysiology and 
membrane trafficking, remain poorly understood. 
2.3. Lipid-Modifying Enzymes (LPAT and PLA2) 
The size and chemical properties of different acyl chains and head groups of phospholipids can 
affect membrane curvature (Figure 1A) [41,42]. Phosphatidic acid (PA) and lyso-PA are interconverted 
by phospholipase A2 (PLA2) and lyso-PA acyl transferase (LPAT) activities, respectively. These lipids 
favor opposite membrane curvatures; lyso-PA and PA can induce budding towards the cytoplasm when 
located in the cytoplasmic and exoplasmic leaflets, respectively [43–45] (Figure 1A). Inhibitors of 
PLA2 prevent formation of membrane tubules from the Golgi apparatus and endosomes, and 
consequently inhibit protein trafficking through these organelles [44]. Conversely, application of 
specific LPAT inhibitors enhances tubulation of the Golgi [46]. Thus, local changes in the shape of 
phospholipids can influence membrane deformation and thereby the formation of carrier intermediates. 
3. Proteins 
3.1. Arf Family Small GTPases 
Small GTPases act as molecular switches that regulate activity and localization of proteins and 
thereby determine the spatial and temporal organization of many cellular processes, including Membranes 2012, 2     123 
 
membrane trafficking. In their GTP-bound active state, members of the Arf family of small GTPases 
promote budding of coated carrier vesicles, such as those coated by the COPI complex and the 
clathrin/AP-1 complex [47]. Members of the Arf family (Arf1-Arf6) are related to a broad set of small 
GTPases [48]. These relatives include Sar1 and a subfamily of Arf-like (Arl) proteins. Arf1, the 
best-characterized member of the Arf subfamily, facilitates recruitment of COPI onto Golgi 
membranes and clathrin to late Golgi and endosomal compartments, both through its direct  
interaction with heterotetrameric adaptor complexes (AP-1, AP-3, AP-4) and monomeric adaptors 
(GGA1−GGA3) [49–51] and through activating lipid-modifying enzymes, including phospholipase D 
and phosphatidylinositol-specific kinases [52–56]. These data indicate that Arf1 acts as a master 
regulator of coated vesicle formation.   
Arf family proteins contain an N-terminal amphipathic helix and a myristoyl group that is usually 
attached to the N terminus (Figure 1A,B). Upon binding to GTP, the Arf molecule undergoes an 
extensive conformational change, during which the interswitch region displaces the N-terminal 
amphipathic helix from a hydrophobic pocket [57,58]. The exposed helix is in turn inserted into an 
adjacent lipid bilayer, and can induce membrane curvature (Figure 1A,B). Indeed, GTP-bound Arf and 
Sar1 molecules effectively tubulate liposomes, whereas GDP-bound forms do not [59–64]. In case of 
Sar1, the exposure of the amphipathic N-terminal helix triggers membrane curvature generation during 
budding of COPII-coated vesicles [60]. Mutations within the N-terminal amphipathic helix of Arf1 
decrease the number of Arf1-induced tubules in vivo and its ability to tubulate liposomes  
in vitro [61,63]. Additional support of this idea is provided by the observation that many 
membrane-deforming proteins, such as endophilins [65,66], epsins [67] and amphiphysins [68,69], 
contain amphipathic helices that can be inserted into the lipid bilayers. These data support a 
mechanistic model in which insertion of N-terminal amphipathic helix of GTP-bound Arf proteins 
leads to bilayer bending upon vesicle budding (Figure 1A).   
3.2. BAR Domain-Containing Proteins 
The BAR domain protein superfamily members have been implicated in membrane traffic, actin 
cytoskeleton remodeling and signal transduction [69–71]. BAR domains constitute a helical 
homodimer [69]. Given that BAR domain homodimers intrinsically adopt curved structures   
(Figure 1C), and that some BAR domain proteins, such as arfaptin and amphiphysin, can tubulate 
liposomes in vitro [68,69], it is likely that BAR domain proteins can generally sense and/or induce 
membrane curvature upon their recruitment from the cytosol onto the membrane surface [72–74]. 
Crystal structures, lipid-binding studies and liposome tubulation assays have validated the BAR 
domain−mediated membrane curvature model and expanded the superfamily; according to sequence 
and structural similarities, the family now comprises classical BAR domain proteins as well as N-BAR, 
F-BAR, I-BAR, BAR-PH, and PX-BAR proteins (see [73,75] for details). N-BAR domain proteins, 
such as amphiphysins and endophilins, have an N-terminal amphipathic helix, and may trigger 
membrane deformation via insertion into lipid bilayers. The BAR domain in turn senses curvature, and 
may thereby play roles in biogenesis of tubular organelles or the generation of endocytic vesicles or Membranes 2012, 2     124 
 
other carrier intermediates [65,69,76]. The observation of crystal structures and cryo-electron 
microscopic analyses suggest that BAR domains self-assemble into larger complexes, and that 
individual domains may be in contact in an organized manner and form BAR domain lattices [77–80]. 
F-BAR domain proteins, such as FCHo and FBP17, sense membrane curvature of clathrin-coated pits, 
oligomerize around the curved membranes, and ultimately induce invagination and tubulation of the 
plasma membrane during endocytosis [73,77,80,81]. BAR domains that sense, and presumably can 
generate curvature can be recruited or activated at buds, tubules or tubular-saccular structures during 
budding processes [74,82,83] (Figure 1A).   
In general, BAR domains bind to acidic membrane surfaces via basic residues on their concave 
face; the binding mode is relatively nonspecific, as compared with other membrane-binding modules 
that recognize head groups of specific phospholipids [69]. Many BAR domains are found in 
conjunction with other membrane-binding modules, such as PH (pleckstrin homology) and PX  
(phox homology) domains, which define membrane-binding specificity, and thereby functional 
specificity, of the BAR domain proteins [70]. For instance, PH domains, which recognize specific 
phosphoinositides, are required for correct membrane association of BAR domain proteins, APPL1 and 
ASAP1 (an ArfGAP) [84,85]. Moreover, a subset of the sorting nexin (SNX) family proteins, 
including SNX1 and SNX9, contain phosphoinositide-binding PX domains in addition to their BAR 
domains. The PX domain of SNX9 binds to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and 
thereby assists in targeting of this SNX-BAR to PtdIns(4,5)P2-enriched regions of endocytic  
pits [86–88]. In contrast, the PX domain of SNX1 associates with the early and late endosomal 
phosphoinositides, respectively phosphatidylinositol 3-phosphate and phosphatidylinositol 
3,5-bisphosphate, helping to target this protein to maturing early endosomes [89–91]. Therefore, the 
PX-BAR-containing SNXs can be selectively targeted to high-curvature membrane domains of cellular 
compartments that are enriched in specific phosphoinositides, and in turn drive membrane tubulation 
in the context of tubule-based sorting [92–94].   
4. Interplay between Regulatory Proteins   
4.1. Membrane Targeting of BAR Domain Proteins by Small GTPases 
The BAR domain protein arfaptin was originally identified as a binding partner of the Arf family of 
small GTPases. We have recently shown that Arl1 (Arf-like 1) interacts with the BAR domain of 
arfaptin in a GTP-dependent manner [95]. Arl1 is localized primarily to the trans side of the Golgi 
complex, where it plays a role in membrane trafficking [96–99]. Overexpression of arfaptin induces 
Golgi-derived membrane tubules, whereas exogenous expression of Arl1 itself neither generates 
membrane tubules nor enhances arfaptin-mediated tubulation. However, association of arfaptin with 
Golgi membranes is abolished by depletion of endogenous Arl1 by RNAi, and rescued by exogenous 
Arl1 expression, indicating that Arl1 is required for targeting arfaptin to Golgi membranes. Although it 
is not clear whether association of Arl1 (or other proteins) or lipid modification provides the initial cue 
for membrane deformation, it is clear that arfaptin molecules recruited onto Golgi membranes through Membranes 2012, 2     125 
 
interaction with Arl1 sense and stabilize membrane curvature, and thereby facilitate tubule formation, 
probably through oligomerization like other BAR domain proteins [77–80] (Figure 1D).   
The early endosomal protein APPL1 interacts with Rab5 via its BAR and PH domains. This 
interaction is critical for targeting of APPL1 to endosomal membranes and APPL-mediated regulation 
of cell proliferation [85,100].   
Thus, in addition to lipid-binding modules, such as PH and PX domains, the Arf and Rab families 
of small GTPases also determine the temporally and spatially confined localization of BAR  
domain proteins. 
4.2. Arf Family Small GTPases and P4-ATPases 
The first indication that P4-ATPases are involved in membrane trafficking came from an Arf1 
synthetic lethal screen in yeast, designed to discover proteins that function together with Arf in vesicle 
budding from the Golgi complex  [15].  DRS2 was identified in this screen. Drs2p localizes 
predominantly to the TGN; Drs2p-deficient cells are morphologically very similar to clathrin  
mutants [15]. As described above, Arf GTPases play an essential role in recruiting vesicle coat proteins, 
such as the COPI complex and the clathrin/AP-1 complex, from the cytosol, in order to induce their 
assembly on Golgi membranes. Genetic interactions were found between drs2, arf and clathrin mutant 
alleles, but not between drs2 and COPI or COPII mutations. Consistent with these genetic interactions, 
clathrin-dependent pathways are strongly perturbed by loss of Drs2p, whereas COPI- and 
COPII-dependent protein trafficking pathways are unaffected [101,102]. Moreover, Drs2p has been 
shown to directly interact with Gea2p, a guanine nucleotide exchange factor for Arf GTPases [103]. 
Because the localizations of Gea2p, AP-1 and clathrin are not affected in drs2 cells [102,103], it seems 
that Drs2p is not required for the recruitment of these proteins, but rather might be involved in the 
membrane deformation process by flipping phospholipids at sites of vesicle budding. 
On the other hand, Neo1p, which is phylogenetically close to mammalian ATP9A and ATP9B 
(Table 1), exhibits genetic and physical interactions with Ysl2p, a potential guanine nucleotide 
exchange factor for Arl1p [104,105]. We and others have previously shown that Arl1 is localized to the 
TGN, where it regulates the retrograde trafficking from endosomes to the Golgi complex in 
mammalian cells [96,98,99]. Moreover, we have recently found that arfaptin (a BAR domain protein; 
see above) is a downstream effector of Arl1 [95], suggesting involvement of Arl1 in the membrane 
deformation machinery during vesicular trafficking (Figure 1D). Given that Neo1p may play a role in 
membrane trafficking within the endosomal/Golgi system [105], and that human ATP9A and ATP9B 
localize to the TGN and endosomes [106], ATP9A and ATP9B might be functionally implicated in the 
post-Golgi membrane trafficking (Figure 1B). 
5. Conclusions 
The curvature generation process is divided into two stages. The first stage is membrane 
deformation. The deformation can be induced by any of the following mechanisms: (i) changes in lipid 
composition (shapes, species and numbers of phospholipids) between two leaflets of the bilayer;  Membranes 2012, 2     126 
 
(ii) insertion of small hydrophobic or amphipathic protein domains into one of the two leaflets; and 
(iii) binding of specific protein domains with an intrinsically curved shape (e.g., BAR domains) to the 
membrane surface, forcing the membrane to assume the shape of the protein domain. The second stage 
is curvature sensing, i.e., the preferential recognition and stabilization of preexisting lipid topologies 
by protein domains with suitable curvature. We favor a model in which BAR domains function to 
sense and stabilize preexisting membrane curvature, rather than to induce curvature. However, the two 
functions are not mutually exclusive, and may occur simultaneously or in a complex fashion. Thus, 
generation of membrane curvature in the context of membrane trafficking and organelle dynamics is 
under complex regulation, involving changes in the composition and distribution of lipids, assembly of 
proteins, and the orchestrated activities of these regulatory proteins. 
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